Literature DB >> 25033964

Advances in understanding of colorectal liver metastasis and implications for the clinic.

Andrew J Page1, David C Cosgrove, Joseph M Herman, Timothy M Pawlik.   

Abstract

Colorectal cancer is one of the most common cancers in both the USA and Europe. Over the course of diagnosis, treatment and surveillance, up to 50% of these patients will develop metastases to their liver. In the past 20 years alone, there have been multiple advances in the management of these colorectal metastases to the liver. These advances have been made in characterization of these tumors, diagnosis and in treatment, both locally and systemically. Because of this progress, there are subsets of patients with this stage IV disease who are cured of their disease. While significant progress has been made, there still exist limitations in the management of metastatic colorectal cancer to the liver. This review outlines current strategies and highlights recent advances in the management of colorectal liver metastases.

Entities:  

Keywords:  ablation; colorectal liver metastases; disappearing liver metastases; outcomes

Mesh:

Year:  2014        PMID: 25033964     DOI: 10.1586/17474124.2014.940897

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  10 in total

1.  Radiofrequency ablation is one of safe and effective local control alternative for colorectal pulmonary metastases.

Authors:  Ke-Neng Chen
Journal:  Ann Transl Med       Date:  2016-08

2.  β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases.

Authors:  Annalen Bleckmann; Lena-Christin Conradi; Kerstin Menck; Nadine Annette Schmick; Antonia Schubert; Eva Rietkötter; Jetcy Arackal; Peter Middel; Alexandra Schambony; Torsten Liersch; Kia Homayounfar; Tim Beißbarth; Florian Klemm; Claudia Binder; Tobias Pukrop
Journal:  Clin Exp Metastasis       Date:  2016-02-09       Impact factor: 5.150

Review 3.  The Potential Role of Liver Transplantation as a Treatment Option in Colorectal Liver Metastases.

Authors:  Pål-Dag Line; Morten Hagness; Svein Dueland
Journal:  Can J Gastroenterol Hepatol       Date:  2018-01-17

4.  Identification of liver metastases with probe-based confocal laser endomicroscopy at two excitation wavelengths.

Authors:  Crispin Schneider; Sean P Johnson; Kurinchi Gurusamy; Richard J Cook; Adrien E Desjardins; David J Hawkes; Brian R Davidson; Simon Walker-Samuel
Journal:  Lasers Surg Med       Date:  2016-12-19       Impact factor: 4.025

Review 5.  Expanding Indications for Liver Transplant: Tumor and Patient Factors.

Authors:  Kevin Ka-Wan Chu; Kelly Hiu-Ching Wong; Kenneth Siu-Ho Chok
Journal:  Gut Liver       Date:  2021-01-15       Impact factor: 4.519

Review 6.  Advances in liver transplantation for unresectable colon cancer liver metastasis.

Authors:  Xiao Cui; Xiao-Ping Geng; Da-Chen Zhou; Ming-Hao Yang; Hui Hou
Journal:  World J Gastrointest Surg       Date:  2021-12-27

Review 7.  Role of liver transplantation in the management of colorectal liver metastases: Challenges and opportunities.

Authors:  Panagiotis T Tasoudis; Ioannis A Ziogas; Sophoclis P Alexopoulos; John J Fung; Georgios Tsoulfas
Journal:  World J Clin Oncol       Date:  2021-12-24

8.  Effect of tumour size ratio on liver recurrence-free survival of patients undergoing hepatic resection for colorectal liver metastases.

Authors:  Yana Zhai; Weijun Bai; Jin Zhou; Qian Dong; Jingdong Zhang
Journal:  BMC Cancer       Date:  2022-01-25       Impact factor: 4.430

Review 9.  Radioembolization treatment for liver metastases.

Authors:  Joanna Kiszkaą; Bożenna Karczmarek-Borowska
Journal:  Contemp Oncol (Pozn)       Date:  2017-12-30

10.  Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases.

Authors:  Olga Østrup; Vegar Johansen Dagenborg; Vigdis Nygaard; Kjersti Flatmark; Einar Andreas Rødland; Veronica Skarpeteig; Laxmi Silwal-Pandit; Krzysztof Grzyb; Audun Elnæs Berstad; Åsmund Avdem Fretland; Gunhild Mari Mælandsmo; Anne-Lise Børresen-Dale; Anne Hansen Ree; Bjørn Edwin
Journal:  Oncotarget       Date:  2017-07-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.